title: [Possibilities of antiviral and immunomodulatory therapy for patients with preinvasive cervical neoplasia].
abstract: Secondary prevention of cervical cancer is the identification and treatment of preinvasive forms of the disease, which include dysplasia or cervical intraepithelial neoplasia. Traditional surgical treatment of preinvasive neoplasia does not always result in elimination of the virus that, in its turn, cannot completely exclude the possibility of recurrence. The article presents references and own observations on possibilities of drug therapy in complex treatment for cervical neoplasia.
authors.forename: E V
authors.initials: EV
authors.lastname: Bakhidze
authors.forename: I V
authors.initials: IV
authors.lastname: Berlev
authors.forename: P A
authors.initials: PA
authors.lastname: Arkhangelskaya
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D052685:Alphapapillomavirus; D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007542:Inosine Pranobex / Q000627:therapeutic use*; D008875:Middle Aged; D030361:Papillomavirus Infections / Q000150:complications; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy* / Q000276:immunology*; D002578:Uterine Cervical Dysplasia / Q000188:drug therapy* / Q000276:immunology* / Q000821:virology
chemical_list: D000276:Adjuvants, Immunologic; D016588:Anticarcinogenic Agents; D000998:Antiviral Agents; D007542:Inosine Pranobex